New spinal stimulator tested in healthy volunteers
NCT ID NCT07217314
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study compares an updated spinal stimulation device (STEPSS) with a current device in 10 healthy adults. Participants lie on their back while small electrodes on the spine send electrical currents, and leg muscle activity is recorded. The goal is to see if the new device works better for future use in spinal cord injury research.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Spinal stimulation device (STEPSS)
- What this could lead to
- If successful, this could lead to better spinal stimulation devices for helping people with spinal cord injuries.
- What could go wrong
- This is a very small, early study in healthy people only, so results may not apply to those with injuries. The devices may not work as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 10 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2025
- Expected to finish
-
Jan 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * At least 18 years of age * Proficient in English * Available for the testing session * Able to give informed consent * Able to tolerate spinal stimulation Exclusion Criteria: * Pregnant (female only). * Untreated severe and persistent problems regulating blood pressure, heart rate, or other automatic functions. * Any past or present injury or disease to the nervous system * Heart or lung disease that may interfere with stimulation * A skin condition in any area that may affect the ability to receive stimulation * Taking any medication that may affect the ability to receive spinal stimulation * Ongoing drug abuse
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy participants are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Kessler Foundation
RECRUITINGWest Orange, New Jersey, 07052, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does it matter where you inject? scientists test Weight-Loss drug in arm, thigh, and belly
- New drug RO7830698 put to the test for COPD
- Three pill versions of one drug go head to head in the bloodstream
- Pfizer tests RSV vaccine aimed at older adults
- Radioactive tracer maps where a new drug goes in the body
- Radioactive tag lets scientists follow an experimental drug through the human body